We recommend that you upgrade to the latest version of your browser.

NOR-SCAD

Spontaneous coronary artery dissection (SCAD) is an important cause of myocardial infarction in otherwise healthy, younger people. Most cases occur in women aged 25–55. The reasons why some individuals develop SCAD, and the risk of recurrence remain unclear. Pregnant or recently pregnant women with SCAD represent a particularly high risk group, and the maternal risk in a subsequent pregnancy are not well established.

Illustration showing spontaneous coronary artery dissection (SCAD) in a coronary artery.

Illustration: BioRender

Illustration showing spontaneous coronary artery dissection (SCAD) in a coronary artery.

NOR‑SCAD is a national, multicenter study recruiting both patients with a prior SCAD and patients admitted with acute SCAD. The study focuses on several areas:

  • Hormones and their influence on SCAD
  • Pregnancy associated SCAD and maternal risk
  • Physical activity and exercise
  • The immune system and inflammatory markers
  • General cardiovascular risk factors
  • Carciac complications and mental health

Study overview

Study 1

  • Retrospective cross‑sectional study (patients with prior SCAD)
  • Status: Recruitment and data collection ongoing.
  • Expected results: 2026–2027.  

Study 2

  • Prospective observational study (patients admitted with acute SCAD)  
  • Status: Recruitment and data collection ongoing. 
  • Study period: 2025–2035.  

How to register for participation? 

Researchers involved

Collaborating centers

  • Research Institute of Internal Medicine (RIIM), Rikshospitalet — Bente Halvorsen (read more
  • Haukeland University Hospital, Dept. of cardiology — Nigussie Bogale 
  • Akershus University Hospital (Ahus), Dept. of cardiology — Oliver Meyerdierks
  • Oslo University Hospital, Ullevål, Dept. of cardiology — Tonje Amb Aksnes and Elisabeth Lie
  • University Hospital of North Norway, Tromsø, Dept. of cardiology — Kristina Fladseth
  • St. Olav’s Hospital, Dept. of cardiology — Ola Kleveland
  • Arendal Hospital, Dept. of cardiology — Slobodan Calic
  • Stavanger University Hospital, Dept. of cardiology
  • Nigussie Bogale, MD/PhD, Haukeland University Hospital
  • Oliver Meyerdierks, MD/PhD, Akershus University Hospital

Study and approvals

  • ClinicalTrials.gov ID: NCT07317323 (external link to Study details
  • REK (Regional Committees for Medical and Health Research Ethics): 853139
  • HelseNorge registration: forthcoming
Portrait picture of Anna
For questions about the project, please contact project coordinator/PhD candidate Anna Sørlie

PhD-fellow Anna Sørlie received startup funding from Bergesen Foundation (Bergesensstiftelsen)

Last updated 1/12/2026